Feb 21
Join us and over 350 attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions working in the biomarker space across multiple therapeutic areas, such as immuno-oncology, neuroscience and cardiology. Featuring nearly 60 presentations, workshops, round-table and panel discussions focused on the key opportunities and challenges in biomarker research, from precision medicine and companion diagnostics through to digital biomarkers and clinical trials. Please join us for our featured presentation "Metabolomics as a Leading Technology in Biomarker Discovery" presented by Dr. Nicolas Schauer.